Catalyst Pharmaceuticals, Inc. (CPRX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$23.99
Day's range
$24.89

Catalyst Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 18.63 M $434.75 M   2.25% 15.19%
VANGUARD GROUP INC 01/29/2026 8.43 M $196.81 M   -3.23% 6.88%
STATE STREET CORP 02/13/2026 6.91 M $161.22 M   7.84% 5.63%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 02/17/2026 4.91 M $114.63 M   -1.28% 4.01%
FUNDSMITH LLP 02/17/2026 3.36 M $78.51 M   0.00% 2.74%
AMERICAN CENTURY COMPANIES INC 02/13/2026 3.03 M $70.61 M   19.66% 2.47%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 3.00 M $69.93 M   21.89% 2.44%
MORGAN STANLEY 02/13/2026 2.93 M $68.47 M   59.11% 2.39%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 2.90 M $67.70 M   0.35% 2.37%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 2.65 M $61.85 M   -25.24% 2.16%
BANK OF AMERICA CORP /DE/ 02/17/2026 2.20 M $51.34 M   -4.00% 1.79%
ROYCE & ASSOCIATES LP 02/09/2026 1.91 M $44.60 M   -6.10% 1.56%
JANUS HENDERSON GROUP PLC 02/17/2026 1.72 M $40.12 M   200.55% 1.40%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/13/2026 1.62 M $37.75 M   23.95% 1.32%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 1.36 M $31.66 M   1.84% 1.11%
INVESCO LTD. 02/19/2026 1.29 M $30.19 M   4.88% 1.06%
BOSTON PARTNERS 02/13/2026 1.23 M $28.54 M   -4.62% 1.00%
NORTHERN TRUST CORP 02/17/2026 1.21 M $28.29 M   -4.11% 0.99%
KENNEDY CAPITAL MANAGEMENT LLC 02/13/2026 1.21 M $28.23 M   14.10% 0.99%
MILLENNIUM MANAGEMENT LLC 02/17/2026 993.65 K $23.19 M   -15.73% 0.81%
GOLDMAN SACHS GROUP INC 03/25/2026 979.54 K $22.86 M   -2.75% 0.80%
VICTORY CAPITAL MANAGEMENT INC 02/13/2026 884.61 K $20.65 M   111.88% 0.72%
RAYMOND JAMES FINANCIAL INC 02/18/2026 841.91 K $19.62 M   8.87% 0.69%
MACQUARIE MANAGEMENT HOLDINGS, INC. 02/17/2026 778.59 K $18.17 M   100.00% 0.64%
LEGAL & GENERAL GROUP PLC 02/09/2026 776.17 K $18.12 M   0.27% 0.63%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 748.78 K $17.48 M   0.69% 0.61%
SYSTEMATIC FINANCIAL MANAGEMENT LP 02/09/2026 723.24 K $16.88 M   5.48% 0.59%
BANK OF NEW YORK MELLON CORP 02/10/2026 700.66 K $16.35 M   -0.47% 0.57%
PRINCIPAL FINANCIAL GROUP INC 02/02/2026 683.68 K $15.96 M   6.97% 0.56%
FEDERATED HERMES, INC. 02/12/2026 663.75 K $15.49 M   70.50% 0.54%
UBS GROUP AG 01/29/2026 648.99 K $15.15 M   9.33% 0.53%
GLENMEDE TRUST CO NA 02/17/2026 618.22 K $14.43 M   100.00% 0.50%
SWEDBANK AB 02/09/2026 616.13 K $14.38 M   0.00% 0.50%
METLIFE INVESTMENT MANAGEMENT, LLC 02/12/2026 594.07 K $13.87 M   -19.68% 0.48%
OBERWEIS ASSET MANAGEMENT INC/ 02/17/2026 586.97 K $13.70 M   11.05% 0.48%
VOYA INVESTMENT MANAGEMENT LLC 02/12/2026 567.44 K $13.24 M   27.12% 0.46%
LSV ASSET MANAGEMENT 02/06/2026 539.90 K $12.60 M   -2.26% 0.44%
PUBLIC SECTOR PENSION INVESTMENT BOARD 02/13/2026 492.94 K $11.51 M   -4.61% 0.40%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 487.14 K $11.37 M   -40.68% 0.40%
GABLES CAPITAL MANAGEMENT INC. 02/06/2026 424.62 K $9.91 M   -2.48% 0.35%
NUVEEN, LLC 02/12/2026 418.52 K $9.77 M   -22.81% 0.34%
PACER ADVISORS, INC. 02/24/2026 393.73 K $9.19 M   -36.58% 0.32%
JUPITER ASSET MANAGEMENT LTD 02/10/2026 390.37 K $9.11 M   -2.67% 0.32%
JW ASSET MANAGEMENT, LLC 02/06/2026 388.39 K $9.07 M   0.00% 0.32%
ABRDN PLC 01/16/2026 387.91 K $9.05 M   -38.66% 0.32%
JPMORGAN CHASE & CO 02/11/2026 369.84 K $8.63 M   -2.37% 0.30%
ALLIANZ ASSET MANAGEMENT GMBH 02/11/2026 366.76 K $8.56 M   -54.04% 0.30%
PRUDENTIAL FINANCIAL INC 02/13/2026 364.82 K $8.51 M   -9.43% 0.30%
BARCLAYS PLC 02/13/2026 358.18 K $8.36 M   -3.95% 0.29%
EVERSEPT PARTNERS, LP 02/17/2026 358.17 K $8.36 M   2.10% 0.29%

Catalyst Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 489 institutional investors and hedge funds held shares of Catalyst Pharmaceuticals Inc. The most heavily invested institutionals were:

DIMENSIONAL FUND ADVISORS LP: 3.43 M

ROYCE & ASSOCIATES LP: 2.09 M

Boston Partners: 1.71 M

UBS Group AG: 986,090

VANGUARD FIDUCIARY TRUST CO: 802,631

Invesco Ltd.: 752,839

84.79% of Catalyst Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 132.58 M shares in the last 24 months. This purchase volume represents approximately $3.29 B in transactions.